Shorten the timeline from research to real world use.

Apply our platforms, OS-T and OS-IP, to vaccine development, therapy response, disease reccurence, and more.

What is OS-T and OS-IP?

Applications

Gain a holistic view of immune system dynamics to inform vaccine development, measure therapy efficacy, and for haematological malignancies detect early traces of disease.

Comprehensive.

Accelerate vaccine development.

Learn more Order

Predictive.

Identify therapy response.

Learn more Order

Sensitive.

Monitor disease recurrence.

Learn more Order

OS-VAX

Accelerate vaccine development.

Identify publicly conserved clonotypes, measure their activation and efficiency against disease and analyze to which epitopes it has been most commonly associated.

For more information, watch the longitudinal COVID-19 case study by Dr. Christian Brander of IrsiCaixa and discover how OS-T can accelerate your vaccine development.
‍

Powered by

and

Rapidly identify promising vaccine candidates.

Inform vaccine design for variants.

Detect and longitudinal track vaccine-induced immunity.

Understand breadth and durability of protective clones.

OS-IMT

Improve immunotherapy.

Track immune response for immunotherapy success.

Powered by

and

Accelerate development of cellular medicine.

Use predictive biomarkers to optimize clinical trials and identify eligible patients.

Assess therapy efficacy by identifying clonotypes associated with therapeutic outcome.

Use AI models to predict patient reaction to therapy.

Optimise therapeutic cell design.

OS-MRD

Monitor disease recurrence early.

Sensitive quantification of Minimal Residual Disease (MRD) for haematological malignancies at high resolution from blood.

Powered by

and

Assess therapy efficacy and optimise personalised medicine approaches.

Identify disease-specific B cell clones.

Track clonal evolution longitudinally.

OS-VAX

Accelerate vaccine development.

Identify publicly conserved clonotypes, measure their activation and efficiency against disease and analyze to which epitopes it has been most commonly associated.

Powered by

OS-T

and

OS-IP

Rapidly identify promising vaccine candidates.

Inform vaccine design for variants.

Detect and longitudinal track vaccine-induced immunity.

Understand breadth and durability of protective clones.

OS-IMT

Improve immunotherapy.

Track immune response for immunotherapy success.

Powered by

OS-T

and

OS-IP

Accelerate development of cellular medicine.

Use predictive biomarkers to optimize clinical trials and identify eligible patients.

Assess therapy efficacy by identifying clonotypes associated with therapeutic outcome.

Use AI models to predict patient reaction to therapy.

Optimise therapeutic cell design.

OS-MRD

Monitor disease recurrence early.

Sensitive quantification of Minimal Residual Disease (MRD) at high resolution from blood.

Powered by

OS-B

and

OS-IP

Assess therapy efficacy and optimise personalised medicine approaches.

Identify disease-specific B cell clones.

Track clonal evolution longitudinally.